Actin-Related Protein-Testis1 (ARP-T1)/ ACTRT1 gene mutations cause the Bazex-Dupré-Christol Syndrome (BDCS) characterized by follicular atrophoderma, hypotrichosis and basal cell cancer. Here, we report an ARP-T1 interactome involved in ciliogenesis, endosomal recycling and septin ring formation (PXD016557). Consequently, ARP-T1 localizes to the midbody during cytokinesis and the basal body of primary cilia in G0. Tissue samples from BDCS patients show reduced ciliary length with significant correlations of ARP-T1 expression levels, confirmed by ACTRT1 knock down. We report that BDCS is a novel ciliopathy and the first case of a skin cancer ciliopathy, where ARP-T1 plays a critical role to prevent pathogenesis.
INTRODUCTION
Basal cell cancer (BCC) of the skin is the most frequent human cancer. Bazex-Dupré-Christol Syndrome (BDCS) is an X-linked dominantly inherited syndrome form of BCC, without male-tomale transmission, affecting primarily the hair follicle (HF), and results in the triad of hypotrichosis, follicular atrophoderma and BCC [1] [2] [3] . Hypotrichosis and follicular atrophoderma develop around birth and BCC early in adulthood. BDCS less frequently presents with milia, hypohidrosis, facial pigmentation and trichoepithelioma, and thus combines developmental cutaneous anomalies with tumor predisposition, i.e. an ectodermal dysplasia with a hereditary tumor syndrome 4, 5 . Unlike most cases of BCC, BDCS is an inherited syndromic form of BCC. The insertion mutation ARP-T1 547_548InsA creating a shift of the reading frame resulting in a truncated protein of 198 amino acids segregates with the disease, and germline mutations of non-coding sequences surrounding ACTRT1 were identified and postulated to belong to enhancers transcribed as non-coding RNAs (eRNAs). ARP-T1 plays a role as a tumor suppressor in BDCS 6 . ARP-T1 was first isolated as a major acidic component of the cytoskeletal calix from the head of bull spermatozoa. ARP-T1 is expressed specifically late in spermatid differentiation in testis, where it locates to the postacrosomal region and the centriole 7 , establishing a link to the primary cilium (PC) of epidermal cells implicated in the BCC development.
Cilia are microtubule-based organelles that are either motile as in sperm propel or nonmotile (primary) acting as sensory antenna, receiving signals from other cells nearby. The sensory capacity of PC is founded on the spatio-temporal localization of diverse receptor complexes such as PTCH, RTKs, TGFβR, NOTCH receptors, GPCRs including SMO, ion channels and extracellular matrix receptors along the cilium 8 . Ciliary communication is often compromised in cancer 9 , and faulty Hedgehog signaling implicated in many cancers, prototypically in medulloblastoma and BCC. Indeed, BCC cells are frequently ciliated, and activated SHH signaling within primary cilia is a key driver in BCC pathogenesis 10 . BCCs generally show abnormal activation of the SHH signaling pathway, ascribing its constitutive activation as a prerequisite for the development of a BCC 11 . SHH signaling in its "off" state is characterized by PTCH1, repressing SMO activity. However, primary cilia have a dual role and are required for or may repress tumor formation 12, 13 depending on the level of the molecular interaction 9 .
PC assembly is a complex process emanating from the mother centriole with its appendages and differentiating upon cell cycle exit into the basal body, which nucleates the PC with apical CEP164 14 , a component of distal appendages, EHD1/EHD3 and SNAP29 15 to initiate primary vesicle formation and ciliogenesis. Assembly of the primary cilium includes recruitment of periciliary membranes, transition zone components and a machinery of intraflagellar transport proteins to form the ciliary vesicle and to set the base for formation of the microtubular ciliary axoneme 15, 16 . The PC is separated from the cytosol by the basal body and anchored by transition fibers/distal appendages in the ciliary pocket or periciliary plasma membrane (PM) 17 . Transition fibers and transition zone with its Y-shaped linkers serve as a ciliary gate for the cilio-cytoplasmic transport sharing some functional similarities with the nuclear pore complex 17, 18 . Polarized membrane trafficking to the cilium and the vesicular transport machinery, which targets Golgi derived vesicles and apical recycling endosomes containing essential cargo, such as G protein-coupled receptors, to the periciliary PM or the ciliary pocket depends on small GTPases, notably RAB8 and RAB11, Rabin8 and the BBSome, a stable complex of seven proteins implicated in the ciliopathy of Bardet-Biedl Syndrome (BBS) 8 .
Here, we demonstrate that ARP-T1 is a ciliary protein and involved in ciliogenesis by directly interacting with the ciliary machinery. Mutation in ARP-T1 as found in the tissues of BDCS patients and knock down of ARP-T1 gives rise to the abnormally shortened cilia caused by a disordered actin cytoskeleton network. Ciliopathies encompass most human organ systems in eyes, nose, ears, organ placement, energy homeostasis, infertility, skeleton, reproductive system, brain, hydrocephalus, heart, chronic respiratory problems, kidney and liver 19 . We report that BDCS is the first ciliopathy of epidermal development and cancer.
RESULTS

ARP-T1 is expressed in differentiated human keratinocytes and human epithelial cells.
We examined the expression of ARP-T1 in normal human epidermal keratinocytes (NHEK) (Fig.  1a ,b) and human immortalized keratinocytes HaCaT (Fig. 1c,d ) cultured under differentiating conditions with high calcium up to seven days. The expression of ARP-T1 increased in a terminal differentiation dependent manner as indicated by the expression of Keratin 10 (K10) in differentiating keratinocytes at both mRNA (Fig. 1a ,c) and protein levels ( Fig. 1b,d , quantified in Extended data Fig. 1a,b ). To investigate whether ARP-T1 expression was only induced in keratinocytes or whether it was related to differentiation, we also analyzed its expression in two differentiating retinal-pigmented epithelial cells, ARPE-19 ( Fig. 1e ,f) and hTERT-RPE1 ( Fig. 1g,h) . These cells were differentiated under serum starvation for 35 days or 48h respectively, assessed by the expression of the differentiation and ciliary protein IFT88 ( Fig. 1f ,h). Similar to keratinocytes, differentiated retinal-pigmented epithelial cells exhibited an increased ARP-T1 expression after differentiation, at both mRNA ( Fig. 1e ,g) and protein levels ( Fig. 1f,h ).
ACTRT1 is regulated by non-canonical hedgehog pathway and protein kinase C.
We previously reported that ACTRT1 inhibits GLI1 expression and is involved in hedgehog (HH) signaling 6 . We treated the hedgehog responsive hTERT-RPE1 cells with Smoothened (SMO) agonist (SAG) which binds to SMO and activates HH pathway, and measured the expressions of ACTRT1 and HH pathway target genes, GLI1 and PTCH1. The expression of ACTRT1 mRNA was increased by SAG treatment in proliferating ( Fig. 2a ) and differentiating ( Fig. 2b) conditions. Comparing both conditions, ACTRT1 mRNA was further induced by SAG after differentiation and serum-starvation. GLI1 and PTCH1 mRNA responded well upon SAG treatment and did not show different expression in serum-starved cells ( Fig. 2a,b ). We used additional SMO activator, purmorphamine to confirm the results with SAG treatment, under differentiating condition. In this case, we also used vismodegib (Smoothened inhibitor used for the treatment of BCC) and both purmorphamine and vismodegib, to understand better the role of ACTRT1 in HH pathway (Fig. 2c ). GLI1 (Fig. 2d ) and PTCH1 ( Fig. 2e ) mRNA expressions were used as controls of HH pathway activation. ACTRT1 mRNA is induced 2.5 fold, GLI1 and PTCH1 mRNA about 2 fold upon purmorphamine treatment similar as the treatment with SAG. GLI1 and PTCH1 expression decreased upon both purmorphamine and vismodegib treatment as expected, but not the expression of ACTRT1 indicating that ACTRT1 mRNA expression is regulated by a non-canonical HH pathway.
A cascade of phosphorylation is known to be involved in HH signaling pathways, e.g. PKC, GSK-3β, S6K, PKA, PI3K, aPKC-ι/λ. To investigate the HH pathway in which ACTRT1 plays a role for basal cell cancer, differentiated NHEK where ACTRT1 is highly expressed, were treated with different kinase inhibitors. The cells treated with GF109203X known as PKC and PKA inhibitor showed significantly decreased expression of ACTRT1 while cells treated with rapamycin (mTOR/S6K inhibitor), LY294002 (phosphoinositide-3-kinase inhibitor) and AG1478 (epidermal growth factor tyrosine kinase inhibitor) showed increased expression of ACTRT1 (Fig. 2f ). We further narrowed down to treat NHEK and HaCaT cells with Gö6976 (PKC α/β inhibitor), Rottlerin (PKC δ inhibitor) and ZIP 2549 (atypical PKC inhibitor, a kind gift from Dr. Anthony Oro). We found that Rottlerin inhibits the expression of ACTRT1 in both NHEK and HaCaT cells, indicating that ACTRT1 mRNA expression is regulated by PKC δ (Fig. 2g,h ).
Two different programs (PhosphositePlus and Swiss Institute of Bioinformatics) predicted several putative phosphorylation sites in ARP-T1 and ARP-T1 547_548insA (Fig. 2i ). One of the predicted phosphorylation sites in C-terminus at S352 position showed similar consensus phosphorylation site specificity with PKC (www.kinexus.ca). We transduced ARP-T1 (W), ARP-T1 547_548insA (M) and vector control (V) tagged with DDK (same sequence as FLAG) into differentiated NHEK and immunoprecipitated using Anti-FLAG M2 affinity gel. We used Phospho-(Ser) PKC substrate antisera, which recognize proteins only when phosphorylated at serine residues surrounded by arginine or lysine at the -2 and +2 positions and a hydrophobic residue at the +1 position (ARP-T1 S352 : MSS*FKQ). This antisera recognized ARP-T1 but not ARP-T1 547_548insA suggesting that ARP-T1 is indeed phosphorylated by PKC and stable while ARP-T1 547_548insA is not phosphorylated by PKC, which lack the phosphorylation site, and therefore is prone to be degraded ( Fig. 2j ).
ARP-T1 interacts with proteins in ciliary machinery
To understand the molecular pathways exploited by ARP-T1, we performed coimmunoprecipitation followed by mass spectrometry analysis to identify proteins interacting with ARP-T1. We transduced ACTRT1 (W), ACTRT1 547_548insA (M) and vector control (V) tagged with DDK (same sequence as FLAG) into the cells and immunoprecipitated using anti-FLAG M2 beads. We found putative interacting proteins in HeLa cells ( Fig. 3a) , serum starved and differentiated hTERT-RPE1 cells (Fig. 3b ), and NHEK (data not shown). ARP-T1 interacts in all cells with proteins involved in primary ciliary machinery. We confirmed these interactions by immunoblot analysis with acetylated Tubulin, TCP8 (one of 8 subunits of chaperonin-containing T-complex), Hsc70, BAG2, -Tubulin, EHD4, Septin2 and Septin9 antisera ( Fig. 3a,b ). While chaperones are often identified to some extent in MSA of precipitates with overexpressed proteins, the high number of spectral hits (Table 1 ) and the location of Septins and EHD4 at ciliary basal body lead us to observe the location of ARP-T1 in ciliated hTERT-RPE1 cells.
We analyzed ciliogenesis in ARPE-19 and hTERT-RPE1 cells, which was induced by serum starvation and differentiation. ARP-T1 localizes to the ciliary base forming a primary cilia structure when we co-stained ARP-T1 with acetylated Tubulin, which stains ciliary axoneme. ARP-T1 colocalized with Rootletin, a major basal body protein, in primary cilia ( Fig. 3c and Extended data Fig. 1c in HaCaT cells). ARP-T1 interacts and forms a complex with -Tubulin, which localizes in the vicinity of the basal body ( Fig. 3d and Extended data Fig. 1d in HaCaT cells). We also confirmed that ARP-T1 co-localizes with EHD4 and Septin2 ( Fig. 3d ). We used proximity ligation assays to further confirm these interactions (Extended data Fig. 1e and 1e ). To reinforce these results, we choose to overexpress EHD4. We transfected hTERT-RPE1 cells with EHD4 (EHD4) and vector control (V) tagged with V5. After immunoprecipitation using anti-V5 beads and immunoblot, we detected ARP-T1 in the EHD4 samples but not in the vector control (Extended data Fig. 1g ). In the same cells, we confirmed that ARP-T1 co-localizes with EHD4 (Extended data Fig. 1h ).
ARP-T1 associates with a ciliopathy in BDCS
Based on the ciliary localization of ARP-T1 and the implication of Septin2 in ciliary length control 20 , we analyzed the ciliary structures in the samples from BDCS patients (ACTRT1 547_548insA, Mutations B2, Mutation A3, Mutation CNE12 6 comparing to the normal hair follicles and the samples from a sporadic BCC patient. First, we observed the ciliary structures by staining with Rootletin and acetylated Tubulin (Rootletin Ac-Tu DAPI in Fig. 4a , top) and confirmed colocalization of ARP-T1 and Rootletin (Rootletin ARP-T1 DAPI in Fig. 4a bottom, individual stainings with Rootletin, acetylated Tubulin or ARP-T1 are shown in Extended data Fig. 2 and 3) . Strikingly, we observed a reduction of ciliary length ( Fig. 4b ) and fluorescence intensity of Rootletin and ARP-T1 ( Fig. 4c,d ) in the BDCS samples compared to the normal hair follicle and sporadic BCC. Ciliary length, Rootletin fluorescence and ARP-T1 fluorescence were particularly reduced in ACTRT1 547_548insA (insA in Fig. 4b-f ) and B2 mutation while less prominently reduced in mutation A2 and CNE12. We also found significant correlations between ARP-T1 fluorescence and ciliary length ( Fig. 4e ) and between ARP-T1 fluorescence and Rootletin fluorescence ( Fig.  4f ). We concluded that BDCS, inherited BCC, unlike sporadic BCC, is a novel ciliopathy and the role of ARP-T1 as a part of cilia is to prevent the disease. To study the role of ARP-T1 in controlling ciliary length in vitro, we performed ARP-T1 knock down experiment in hTERT-RPE1 cells. We found that the lengths of cilia stained with acetylated Tubulin in ACTRT1 knock down cells were reduced approximately 25% compared to control cells ( Fig. 4g and shown by quantification in Fig.  4h ) with 65% (KD1) and 50% (KD2) of knock down efficacy at ACTRT1 mRNA ( Fig. 4i ) and ARP-T1 ( Figure 4J ) levels. These results were confirmed in HaCaT cells, in which cilia length was divided by two with 70% of ACTRT1 mRNA KD1 ( Fig. 4k-n) . Therefore, ARP-T1 is required for the maintaining of normal length of cilia in vitro. In sum, ARP-T1 is located in ciliary basal body and regulates ciliogenesis both in vivo and in vitro. Absence of ARP-T1 gives rise to an epidermal ciliopathy.
ARP-T1 is located in midbody in dividing cells.
It was reported that Septin 2 acts as a scaffold for myosin II and its kinases at the cleavage furrow 21 and that Septin 9 mediates midbody abscission during cytokinesis 22 . We, therefore, searched for the localization of ARP-T1 in dividing cells. ARP-T1 localized at the midbody in hTERT-RPE1 cells ( Fig. 5a ), HeLa cells ( Fig. 5b ) and HaCaT cells ( Fig. 5c ). Postmitotic midbody is directly implicated in primary ciliogenesis. After cytokinesis, the midbody remnant moves along the apical surface, proximal to the centrosome at the center of the apical surface where the primary cilium emerges. The midbody remnant carries Rab8, IFT20, IFT88 and exocyst subunits required for ciliogenesis. If the remnant is removed, primary ciliogenesis is greatly impaired 23 . Midbody remnant licenses primary cilia formation 24 . Both midbodies and primary cilia contain acetylated tubulin, many proteins in the midbody can also be found at the base of the cilium in the centrosome 25 . However, ACTRT1 knock down has no obvious impact on cell division (data not shown).
DISCUSSION
Here, we report that ARP-T1 is a ciliary protein located at the basal body of primary cilia. BDCS tumors and ARP-T1 deficient RPE cells show shortened primary cilia. Thus, BDCS is a novel and first ciliopathy implicated in skin cancer caused by mutations of ACTRT1. ARP-T1 supports intact cilia and actin cytoskeleton network to control proper ciliogenesis. ARP-T1 is highly expressed during epidermal differentiation, is stabilized by protein kinase C and ACTRT1 expression is regulated by protein kinase C δ and by a non-canonical Hedgehog pathway. ACTRT1/ARP-T1 regulation has not been described yet. Here, we showed that HH and mTORC2/PKC delta pathways positively regulate ACTRT1 at the mRNA level. HH signaling is activated upon cell differentiation, at the cilium, and is known to induce canonical and noncanonical pathways. As we previously reported that ARP-T1 activates the HH signaling 6 , it was important to decipher a possible feedback loop with this pathway. We found that SMO activation favors ACTRT1 mRNA expression. However a blockade with Vismodegib, drug used in the clinic to treat BCC patients, could not reverse Purmorphamine-induced ACTRT1 mRNA. We concluded that ACTRT1 is regulated by a non-canonical HH signaling. We next unraveled which phosphorylation pathway was implicated in this non-canonical HH signaling. MAP kinase inhibition with PD98059 had no effect on ACTRT1 expression. By using PI3K/mTORC1/S6K and mTORC2/PKC delta inhibitors, we could demonstrate that the proliferating signaling PI3K/mTORC1/S6K limits ACTRT1 expression while its differentiating counterpart mTORC2/PKC delta favors it. These findings highlight the role of HH and mTORC2/PKC delta pathways in ACTRT1/ARP-T1 regulation.
By MS analysis, we identified a machinery of molecular ARP-T1 interactors involved in PC formation (see Table 1 ): (1.) Chaperon containing TCP-1 (CCT/TRiC), consists of two identical stacked rings, each containing eight subunits (TCP1-8). The complex folds various proteins including actin and tubulin. It was shown that CCT/TRiC family chaperonin localizes to centrosomes and forms a complex with BBS proteins, BBS6, BBS10, and BBS12 and mediate the assembly of the BBSome, involved in ciliogenesis regulating transports of vesicles to the cilia 26 . This BBSome protein complex binds to Rabin8, the GTP/GDP exchange factor, for the small GTPase RAB8. RAB8 localizes to the cilium, is required for ciliogenesis, and mediates the docking and fusion of vesicles. It was proposed that the BBSome acts upstream of RAB8 in this vesicular transport to the cilium 27 . BBS causing IFT27 mutations point to a link of the BBSome with IFT where this small GTPase might be involved in delivering cargo from the BBSome to the IFT 28 ; (2.) CCT and heat shock cognate 71 kDa protein (Hsc70) form a stable complex and this interaction was suggested to serve to deliver the unfolded substrate from Hsc70 to the substrate binding region of CCT 29 . Hsc 70 interacts with IFT88 302 . Bcl2-associated athanogen (BAG2) protein forms a chaperone complex with Hsc70 and regulates their protein folding activity 31 ; (3.) The Eps15 homology domain (EHD) family of proteins, composed of EHD1-4, is associated with Rab8 and Rab11 membranes and regulates endosomal membrane trafficking 32 . EHD4 locates to the transition zone of cilia and plays a role in protein transport to cilia and ciliogenesis. EHD4 deficient mice show a strong phenotype in skin, kidney and testis with small testis, reduced sperm motility, sperm number and germ cells, such that Ehd4-/-mice are subfertile. Approximately 50% of all EHD4-deficient mice suffer from reduced number of hairs (hypotrichosis) at the dorsal back and have a primary cilia phenotype (Dr. Markus Plomann, unpublished data); (4.) Septin2 localizes at the base of the axoneme. Cells completely depleted of Septin2 lack a cilium whereas cells partially depleted at the base of primary cilia have a significantly shorter cilium than control 20 . Septin2 interacts with Hsc70 33 . Septin9 has been shown to interact with microtubules 34 and localizes to the ciliary pocket region 35 . Primary cilia in Septin9 depleted cells are shorter than that in control cells 36 . -Tubulin associates with centrosomes and localizes to the vicinity of basal body 37 .
Overall, our MS results point to a function of ARP-T1 in the ciliary basal body at the crossroads of vesicle trafficking, protein folding and the cytoskeleton (Supplementary Table 1 ). The ciliary pocket or periciliary PM serves as an interface with the actin cytoskeleton, which is important for the movement of the basal body to the PM and for vesicular and endosomal trafficking 38 10 39,40 . We hypothesize that ARP-T1 is functional at this interface and may stabilize the cytoskeletal matrix.
Functional genomic screening showed that proteins involved in actin dynamics and endocytosis are important for ciliogenesis. Depletion of gelsolin family proteins (GSN and AVIL), which regulate cytoskeletal actin organization by severing actin filaments, reduced the number of ciliated cells and silencing of ACTR3 (ARP-3), a major constituent of the ARP2/3 complex involved in nucleating actin polymerization, increased cilium length 41 . On the other hand, it was reported that the actin cytoskeleton is disrupted in knockdown cell lines targeting ciliary proteins. For example, Ahi1, whose human ortholog is mutated in Joubert syndrome, knockdown cells showed disorganizing and decrease in actin filaments 42 . ARP-T1 has 49 % identity with β-actin and 40%, 37%, 29% identity with ARP-1, ARP-2, ARP-3, respectively. ARP-T1 as a ciliary protein is involved in a positive regulation of ciliogenesis. Similar case as ARP-T1, some cancer-associated mutations result in ciliary resorption. Von Hippel-Lindau (VHL) disease is characterized by the development of premalignant renal cysts, and arises because of functional inactivation of VHL tumor suppressor protein (pVHL). It maintains the structural integrity of the primary cilium for suppression of uncontrolled proliferation of kidney epithelial cells and cyst formation 43 . It was shown by electron microscopy that glioblastoma cells and tumors have immature primary cilia and basal body/centrioles 44 45 . Mutations in Budding uninhibited by benzimidazole-related 1 (BUBR1), a molecule of spindle assembly checkpoint, cause premature chromatid separation (mosaic variegated aneuploidy), cancer disposition and impaired ciliogenesis 46 .
With our results, we propose a model where ARP-T1 leads primary ciliogenesis via direct interaction with proteins in ciliary machinery. First, ARP-T1 presents in the mitotic spindle through the interaction with gamma Tubulin which presents in between the mother centriole and the daughter centriole (Fig. 5d ). As the cytokinesis proceeds, the complex of ARP-T1 and two centriols moves to the central spindle where the midbody is formed by recruiting Septins (Fig. 5e ). The midbody cleaves one side of intracellular bridge and remains tethered to one of the daughter cells. The complex of ARP-T1, two centriols and midbody move towards the apical surface of daughter cells where primary cilia will be formed ( Fig. 5f,g) .
Dynamic Hh signaling has been identified in mammalian post-natal testis, and SHH pathway components PTCH1, SUFU and GLI-1 were identified in spermatogonia, spermatocytes and spermatids 47 , where spermatids express high levels of SUFU to repress SHH activity 48 . Interestingly, ARP-T1 locates to the centrosome in early stages of mouse testis differentiation and relocates to cytoplasm and cell membrane at later stages. We previously reported that ARP-T1 binds to the GLI1 promoter and inhibits GLI1 mRNA expression signaling 6 . In this study, we showed that the elevated level of ARP-T1 with purmorphamine were not decreased by the treatment with purmorphamine and vismodegib ( Fig. 2c-e ). Thus, ACTRT1 functions in a SMO independent HH pathway. The activation of a non-canonical HH pathway may explain the apparent paradox that we observed shortened primary cilia both in BCC from BCDS and in ACTRT1 knocked down RPE cells. While loss of primary cilia is observed in diverse cancer where it correlates with worse prognosis, their retention is paramount for medulloblastoma and BCC development 9 . Nevertheless, SMO-independent operation occurs both in medulloblastoma 12 and BCC mouse models 13 , and was recently linked to development of resistance to SMO-inhibition 49 . This suggest BDCS is a model for studying vismodegib resistance in BCC and medulloblastoma. We did not study the role of Ras/RhoA pathway, a second non-canonical HH signaling in ARP-T1 expression. Yet, it would an interesting target as it regulates the actin and cortactin cytoskeleton dynamics.
Our results show that ARP-T1 acts as a direct or indirect actor in a non-canonical HH pathway and bridges between actin cytoskeleton organization involved in vesicle transport at the centrosome, the centrioles and the basal body, and the formation of primary cilia to prevent the pathogenesis of BDCS. Above all, our studies shed light on how ciliogenesis is controlled in carcinogenesis by ARP-T1. ARP-T1 could be a new target and novel therapeutic approaches in BDCS and BCC, the most frequent human cancer. This appears particularly important since loss of primary cilia as reported here in BDCS is a recognized mechanism of resistance to SMO inhibitors in medulloblastoma and BCC 49 .
Online METHODS
Cell Culture and samples
Human neonatal foreskin keratinocytes (NHEK, established in our laboratory) and HaCaT cells (Invitrogen, Basel, Switzerland) were grown in EpiLife medium (Gibco, Invitrogen, Basel, Switzerland) with Human Keratinocyte Growth Supplement (Gibco, Invitrogen, Basel, Switzerland), 10 µg/ml gentamicin and 0.25 µg/ml amphotericin B (Gentamicin / Amphotericin B solution, Gibco, Invitrogen, Basel, Switzerland). ARPE-19 and hTERT-RPE1 (ATCC, Manassas, VA) cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) High Glucose, GlutaMAX™, Pyruvate (Gibco, Invitrogen, Basel, Switzerland) or DMEM/F12 (ATCC) with 0.01 mg/ml hygromycin B (Sigma-Aldrich, St Louis, MO), both media supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin (BioConcept AG, Allschwil, Switzerland). HeLa and HEK293T (Invitrogen) were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. The cells were incubated at 37°C in a 5% CO2 atmosphere.
To induce cilia formation, NHEK and HaCaT were cultured up to 7 days in EpiLife media supplemented with 2 mM CaCl2. hTERT-RPE1 and ARPE-19 cells were cultured 48h or 35 days respectively in media containing 0.2% FBS.
Bazex-Dupré-Christol syndrome samples were collected and prepared as previously described in 6 .
Lentivirus
Lentivirus particles for ACTRT1 overexpression were produced with Calcium phosphate transfection method: ACTRT1 wild-type (WT) and mutant containing the c.547-548InsA mutation constructs were produced as previously described in 6 . HEK293T cells were transiently cotransfected with psPAX2 (Addgene, Cambridge, MA) and pMD2.G (Addgene, Cambridge, MA) and empty vector or ACTRT1 WT or mutant to produce lentiviral particles (LVs). LVs were harvested 48 hours later and the titer was determined in HeLa cells 50 .
Lentiviral particles for ACTRT1 shRNA were produced by Sigma-Aldrich, in pLKO backbone vector. ShRNA sequences are for ACTRT1 KD1: 5' CCG GGC CTG GTT TCT ACC TGT CTA ACT CGA GTT AGA CAG GTA GAA ACC AGG CTT TTT G 3', and ACTRT1 KD2: 5' CCG GGT GCC TTT AGC AAG ACT TAA TCT CGA GAT TAA GTC TTG CTA AAG GCA CTT TTT TG 3'. Control is an empty vector with same selection.
Viral transduction
HeLa, hTERT-RPE1 and HaCaT cells were transduced using polybrene (8 ug/mL, TR1003, Millipore), with lentivirus O/N at 37°C. The next day, lentivirus was removed and cells grew in their medium. Selection with puromycin (2.5 ug/mL, 540411, Calbiochem) or blasticidin (7.5 ug/mL, 15205, Sigma-Aldrich) started 24h later. 
Drug Treatments
Western blot
NHEK, HaCaT, ARPE-19, and hTERT-RPE1 cells were harvested in ice-cold FLAG (50 mM Tris/Cl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease inhibitor cocktail [Complete MiniTM tablette, Roche Diagnostics]) or RIPA (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 12 mM Na deoxycholate, 1% NP-40, 0.1% SDS, protease inhibitor cocktail,and phosphatase inhibitor cocktail [PhosSTOP, PHOSS-RO, Roche]) lysis buffer for 30 min on ice with extensively pipetting every 10 min, then spun for 10 to 20 min at 12,000 x g at 4°C. Supernatants were collected, heated for 5 min at 85°C and centrifuged. Total protein concentration was determined by BCA assay (PierceTM BCA Protein Assay Kit; Thermo Scientific, Waltham, MA, USA). Fifteen ug of proteins were loaded onto a 10% SDS-PAGE gel and electroblotted onto a nitrocelulose or PVDF membrane membrane (Hybond ECL; Amersham, UK). Membranes were incubated with the following antibodies: anti-ARP-T1 (1:1000, SAB1408334, Sigma-Aldrich / 1:2000, GP-SH6, Progen), anti-Keratin 10 (1:200, MS-611-P0, Thermo Scientific), anti-Actin (loading control, 1:2000, A2066, Sigma-Aldrich) and anti-Tubulin (1:5000, T9026, Sigma-Aldrich). After washes in TBT-T, incubation with HRP-secondary antibodies (anti-mouse (1:5000, NA931V, GE Healthcare UK Limited), anti-rabbit (1:5000, NA934V, GE), anti-guinea pig (1:5000, ab97155, Abcam), and revelation with chemiluminescence, images were acquired using the Luminescent Image Analyzer LAS-4000 mini (Fujifilm, Tokyo, Japan). Band intensity was analyzed with Image J software (National Institutes for Health, USA).
Co-immunoprecipitation
Transduced HeLa, NHEK, and serum-starved hTERT-RPE1 cells were washed with PBS and harvested in the FLAG lysis buffer. Supernatants were incubated with 30 μl anti FLAG-beads (ANTI-FLAG TM M2 Affinity Gel) overnight at 4°C and 1h at room temperature (RT) on a rotator to pool-down ARP-T1-FLAG protein. Beads were separated by centrifugation for 3 min at 5000 x g, washed five times with TBS, and eluted in 23 μl TBS and 7 μl 5x SDS-sample buffer at 85°C for 5 min. ARP-T1 precipitation was confirmed using ARP-T1 antiserum (1:2000, Progen GP-SH6), and co-precipitated protein were analyzed using anti-Acetylated-Tubulin (1:1000, T6793, Sigma-Aldrich), anti-TCP8 / TCP1 theta (1:500, PA5-30403, Thermo Scientific), anti-Hsc70 (1:200, PA5-27337, Thermo Scientific),anti-BAG2 (1:100, PA5-30922, Thermo Scientific), anti-gamma-tubulin (1:500, #ab11316, Abcam), anti-EDH4 (1:1000 kindly given by Prof. Plomann), anti-Septin2 (1:2000, HPA018481, Sigma-Aldrich), anti-Septin9 (1:2000, HPA042564, Sigma-Aldrich).
Proteomic analysis/ Mass Spectrometry
Transduced HeLa, NHEK, and serum--starved hTERT-RPE1 cells were washed with PBS and harvested in FLAG lysis buffer, and analyzed by the Proteomic Analysis Facility of University of Lausanne with the following protocol.
Gel separation and protein digestion
Protein samples were loaded on a 12 % mini polyacrylamide gel and migrated about 2.5 cm in non-reducing conditions. After Coomassie staining, gel lanes between 15-300 kDa were excised into 5-6 pieces, and digested with sequencing-grade trypsin (Promega) as described by Shevchenko and colleagues 51 . Extracted tryptic peptides were dried and resuspended in 0.05% trifluoroacetic acid, 2% (v/v) acetonitrile for mass spectrometry analyses.
Mass spectrometry analyses
Tryptic peptide mixtures were injected on a Dionex RSLC 3000 nanoHPLC system (Dionex, Sunnyvale, CA, USA) interfaced via a nanospray source to a high resolution mass spectrometer based on Orbitrap technology: Orbitrap Fusion Tribrid or QExactive Plus instrument (Thermo Fisher, Bremen, Germany), depending on the experiments considered. Peptides were loaded onto a trapping microcolumn Acclaim PepMap100 C18 (20 mm x 100 μm ID, 5 μm, Dionex) before separation on a C18 reversed-phase analytical nanocolumn, using a gradient from 4 to 76 % acetonitrile in 0.1 % formic acid for peptide separation (total time: 65min). Q-Exactive Plus instrument was interfaced with an Easy Spray C18 PepMap column (25 cm x 75µm ID, 2µm, 100Å, Dionex). Full MS survey scans were performed at 70,000 resolution. In datadependent acquisition controlled by Xcalibur software (Thermo Fisher), the 10 most intense multiply charged precursor ions detected in the full MS survey scan were selected for higher energy collision-induced dissociation (HCD, normalized collision energy NCE=27 %) and analysis in the orbitrap at 17'500 resolution. The window for precursor isolation was of 1.5 m/z units around the precursor and selected fragments were excluded for 60s from further analysis.
Orbitrap Fusion Tribrid instrument was interfaced with a reversed-phase C18 Nikkyo column (75 μm ID x 15 cm, 3.0 μm, 120Å, Nikkyo Technos, Tokyo, Japan) or a custom packed column (75 μm ID × 40 cm, 1.8 μm particles, Reprosil Pur, Dr. Maisch). Full survey scans were performed at a 120'000 resolution, and a top speed precursor selection strategy was applied to maximize acquisition of peptide tandem MS spectra with a maximum cycle time of 3s. HCD fragmentation mode was used at a normalized collision energy of 32%, with a precursor isolation window of 1.6 m/z, and MS/MS spectra were acquired in the ion trap. Peptides selected for MS/MS were excluded from further fragmentation during 60s.
Data analysis
MS data were analyzed using Mascot 2.5 (Matrix Science, London, UK) set up to search the Swiss-Prot (www.uniprot.org) database restricted to Homo sapiens taxonomy (UniProt, December 2015 version: 20'194 sequences). Trypsin (cleavage at K,R) was used as the enzyme definition, allowing 2 missed cleavages. Mascot was searched with a parent ion tolerance of 10 ppm and a fragment ion mass tolerance of 0.50 Da (Orbitrap Fusion) or 0.02 Da (QExactive Plus). Carbamidomethylation of cysteine was specified in Mascot as a fixed modification. N-terminal acetylation of protein and oxidation of methionine were specified as variable modifications.
Scaffold software (version 4.4, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications, and to perform dataset alignment. Peptide identifications established at lower than 90.0% probability by the Scaffold Local FDR algorithm were filtered out. Protein identifications were accepted if they could be established at greater than 95.0% probability and contained at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm 52 . Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony. Proteins sharing significant peptide evidence were grouped into clusters.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium 53 via the PRIDE 54 partner repository with the dataset identifier PXD016557 and 10.6019/PXD016557.
Immunofluorescence
Cells grown on coverslips were fixed in 4% formaldehyde/PBS for 20 min at RT, then permeabilized in 0.02% Triton-X/PBS for 10 min. Coverslips were incubated with blocking buffer containing 1% FBS and 2% bovine serum albumin (BSA) for 1h. Primary antibodies (anti-ARP-T1 (1:100, #SAB2103464; 1:200, Progen GP-SH6), anti-Acetylated-Tubulin (1:1000, T6793), anti-Rootletin (1:50, sc-67824, Santa-Cruz; 1:200, NBP1-80820, Novus), anti-gamma-tubulin (1:500, ab11316, Abcam), anti-EDH4 (1:200, kind gift by Prof. Plomann), anti-Septin2 (1:100, HPA018481, Sigma-Aldrich) were diluted in blocking buffer and applied on the cells for 2h at RT or overnight at 4°C. Coverslips were next incubated with secondary antibodies (1:500, A11008, A11001, A21467, A11035, A11003, A11060, Invitrogen; 1:100, BA-9500, Vector Laboratories; 1:200, RPN1233V, GE) for 1h at RT. Nucleus was stained with DAPI or Hoechst for 5 min at RT. Finally, coverslips were mounted onto slides with Dako mounting medium (Dako Schweitz AG, Baar, Switzerland) and examined with an inverted Zeiss LSM 700 laser scanning confocal microscope equipped with laser diode 405/488/555, SP490/SP555/LP560 emission filters, 2 PMT detectors and Zen2010 software (Zeiss, Feldbach, Switzerland).
Three-dimensional (3D) imaging technique was used to study ciliary imaging. Confocal images were captured at ~0.33-1 µm interval using 63 x/1.40 oil objectives. Using Image J software, the 3D structure was deconvoluded from the Z-stack, and the length, intensity and prevalence of cilia were manually traced and measured. Both cell number and proportion of cells exhibiting primary cilia were determined in approximately five representative fields (100 to 200 μm 2 ) for each experimental condition. The mean cilia prevalence was expressed as the percentage of ciliated cells. The average cilia length was expressed in µm. The ciliary rootlet was selected using the freehand tool and the average area was expressed in µm 2 . The average pixel fluorescence intensity of proteins was quantified using the freehand tool to select the area of interest. Twenty to 50 cilia were measured for each experimental condition.
RNA extraction and Real time quantitative PCR.
Total RNA were harvested using the Qiagen RNeasy Mini Kit (Qiagen, Hombrechtikon, Switzerland) according to the manufacturer's instructions. RNA quantity and quality were assessed using the NanoDrop ND-1000 Spectophotometer (Wilmington, USA). RNA were reverse-transcribed using the Primescript RT reagent kit (TakaRa, Saint-Germain-en-Laye, France) in 10 µl reaction on a T-Gradient Thermocycler (Biometra, Biolabo, Châtel-St-Denis, Switzerland). Quantitative PCR (qPCR) was performed on cDNA with Power SYBRGreen PCR Mastermix (Applied Biosystems, CA, USA) on an Applied Biosystems StepOne thermal cycler (Applied Biosystems, Life Technologies, CA, USA). Gene expression was assessed by using ACTRT1 (QT00215642, Qiagen), GLI1 (Fw 5' AGA GGG TGC CAT GAA GCC AC 3', Rev 5' AAG GTC CCT CGT CCA AGC TG 3', Microsynth), PTCH1 (Fw 5' GCT ACT TAC TCA TGC TCG CC 3', Rev 5' TCC GAT CAA TGA GCA CAG GC 3', Microsynth) primers. RPL13A (Fw 5'GCA TCC CAC CGC CCT ACG AC 3', Rev 5' CTC TTT CCT CTT CTC CTC CA 3', Microsynth) was used as endogenous control. Relative gene expression is normalized to the control and reported with a log2 scale.
Statistics/Data analysis
We used the one-way ANOVA or the Kruskal-Wallis test, depending on homogeneity of variances, to compare one independent variable in more than two groups. Linear regression was used to compare the correlation between two parameters.
To compare gene expression quantified by RT-qPCR, for each gene, all samples were normalized to the control, and log-2 transformed fold changes comparison to 0 were performed with a onesample t test. To compare protein expression, all samples were normalized to the control, and fold changes comparison to 1 were performed with a one-sample t test.
All statistical analyses were performed using Prism GraphPad (v8, La Jolla, CA, USA).
presented as means ±S.D of the fold change compared to the value of undifferentiated samples. b,d,f,h, ARP-T1 expression during the differentiation of keratinocytes, NHEK (b) and HaCaT (d), and epithelial cells, ARPE19 (f) and hTERT-RPE1 (h). ARP-T1 was detected using guinea pig anti-ARP-T1 antisera (b) or rabbit antibody (d,f,h). * indicates polymers of ARP-T1 confirmed by mass spectrometry analysis. Keratin 10 and IFT88 were used as markers of cell differentiation in keratinocytes and epithelial cells respectively, actin and alpha-tubulin as loading controls. 
